Search

Author/Creator Kornblau, Steven M

1. 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial. Issue 10 (October 2020)

Authors:
DiNardo, Courtney D; Maiti, Abhishek; Rausch, Caitlin R; Pemmaraju, Naveen; Naqvi, Kiran; Daver, Naval G; Kadia, Tapan M; Borthakur, Gautam; Ohanian, Maro; Alvarado, Yesid; Issa, Ghayas C; Montalban-Bravo, Guillermo; Short, Nicholas J; Yilmaz, Musa; Bose, Prithviraj; Jabbour, Elias J; Takahashi, ...
Journal:
Lancet
Issue:
Volume 7:Issue 10(2020)
Page Start:
e724
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Treatment with a 5-day versus a 10-day schedule of decitabine in older patients with newly diagnosed acute myeloid leukaemia: a randomised phase 2 trial. Issue 1 (January 2019)

Authors:
Short, Nicholas J; Kantarjian, Hagop M; Loghavi, Sanam; Huang, Xuelin; Qiao, Wei; Borthakur, Gautam; Kadia, Tapan M; Daver, Naval; Ohanian, Maro; Dinardo, Courtney D; Estrov, Zeev; Kanagal-Shamanna, Rashmi; Maiti, Abhishek; Benton, Christopher B; Bose, Prithviraj; Alvarado, Yesid; Jabbour, Elias;...
Journal:
Lancet
Issue:
Volume 6:Issue 1(2019)
Page Start:
e29
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search